Literature DB >> 18079736

Monoallelic or biallelic LMO2 expression in relation to the LMO2 rearrangement status in pediatric T-cell acute lymphoblastic leukemia.

P Van Vlierberghe, H B Beverloo, J Buijs-Gladdines, E R van Wering, M Horstmann, R Pieters, J P P Meijerink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 18079736     DOI： 10.1038/sj.leu.2405063

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  9 in total

1.  Activation of the LMO2 oncogene through a somatically acquired neomorphic promoter in T-cell acute lymphoblastic leukemia.

Authors:  Sunniyat Rahman; Michael Magnussen; Theresa E León; Nadine Farah; Zhaodong Li; Brian J Abraham; Krisztina Z Alapi; Rachel J Mitchell; Tom Naughton; Adele K Fielding; Arnold Pizzey; Sophia Bustraan; Christopher Allen; Teodora Popa; Karin Pike-Overzet; Laura Garcia-Perez; Rosemary E Gale; David C Linch; Frank J T Staal; Richard A Young; A Thomas Look; Marc R Mansour
Journal:  Blood       Date:  2017-03-07       Impact factor: 22.113

Review 2.  The genetics and mechanisms of T cell acute lymphoblastic leukaemia.

Authors:  Laura Belver; Adolfo Ferrando
Journal:  Nat Rev Cancer       Date:  2016-07-25       Impact factor: 60.716

3.  Characterization of a pediatric T-cell acute lymphoblastic leukemia patient with simultaneous LYL1 and LMO2 rearrangements.

Authors:  Irene Homminga; Maartje J Vuerhard; Anton W Langerak; Jessica Buijs-Gladdines; Rob Pieters; Jules P P Meijerink
Journal:  Haematologica       Date:  2011-11-04       Impact factor: 9.941

4.  Lmo2 induces hematopoietic stem cell-like features in T-cell progenitor cells prior to leukemia.

Authors:  Susan M Cleveland; Stephen Smith; Rati Tripathi; Elizabeth M Mathias; Charnise Goodings; Natalina Elliott; Dunfa Peng; Wael El-Rifai; Dajun Yi; Xi Chen; Liqi Li; Charles Mullighan; James R Downing; Paul Love; Utpal P Davé
Journal:  Stem Cells       Date:  2013-05       Impact factor: 6.277

5.  High expression of LMO2 predicts a favorable outcome in adult patients with BCR/ABL negative B-cell acute lymphoblastic leukemia.

Authors:  Rabab M Aly; Mona M Taalab; Eman M Abdsalam; Omar H Elyamany; Omar E Hasan
Journal:  Oncol Lett       Date:  2016-01-19       Impact factor: 2.967

6.  Loss-of-function mutations of Dynamin 2 promote T-ALL by enhancing IL-7 signalling.

Authors:  C S Tremblay; F C Brown; M Collett; J Saw; S K Chiu; S E Sonderegger; S E Lucas; R Alserihi; N Chau; M L Toribio; M P McCormack; M Chircop; P J Robinson; S M Jane; D J Curtis
Journal:  Leukemia       Date:  2016-04-27       Impact factor: 11.528

Review 7.  The Genetics and Mechanisms of T-Cell Acute Lymphoblastic Leukemia.

Authors:  Francesca Gianni; Laura Belver; Adolfo Ferrando
Journal:  Cold Spring Harb Perspect Med       Date:  2020-03-02       Impact factor: 6.915

Review 8.  The role of noncoding mutations in blood cancers.

Authors:  Sunniyat Rahman; Marc R Mansour
Journal:  Dis Model Mech       Date:  2019-11-26       Impact factor: 5.758

9.  Small molecule inhibits T-cell acute lymphoblastic leukaemia oncogenic interaction through conformational modulation of LMO2.

Authors:  Leanne Milton-Harris; Mark Jeeves; Sarah A Walker; Simon E Ward; Erika J Mancini
Journal:  Oncotarget       Date:  2020-05-12
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.